BridgeBio Pharma, Inc. (BBIO)
70.91
-0.12
(-0.17%)
USD |
NASDAQ |
Mar 17, 16:00
70.91
0.00 (0.00%)
After-Hours: 18:40
BridgeBio Pharma Total Assets (Quarterly) : 936.02M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.265B |
| Pfizer Inc. | 208.16B |
| Mirum Pharmaceuticals, Inc. | 842.81M |
| Supernus Pharmaceuticals, Inc. | 1.614B |
| Cogent Biosciences, Inc. | 937.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.013B |
| Shareholders Equity (Quarterly) | -2.087B |
| Debt to Equity Ratio | -1.308 |
| Current Ratio | 2.770 |
| Net Debt Paydown Yield | -1.34% |